Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cancer Prevention Research

• Publication date

  2008-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1940-6207.CAPR-08-0042PMID 18841250PMCID PMC2562024
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relation Between Medicare Screening Reimbursement and Stage at Diagnosis for Older Patients With Colon Cancer

  2008cited by this paper
• Cancer prevention research

  2008cited by this paper
• Cancer Statistics, 2007

  2007cited by this paper
• Infant mortality statistics from the 2004 period linked birth/infant death data set.

  2007cited by this paper
• Rationale for, and design of, a clinical trial targeting polyamine metabolism for colon cancer chemoprevention

  2007cited by this paper
• The dilemma and promise of cancer chemoprevention

  2006cited by this paper
• Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer.

  2006cited by this paper
• A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.

  2006cited by this paper
• Celecoxib for the prevention of sporadic colorectal adenomas.

  2006cited by this paper
• Celecoxib for the prevention of colorectal adenomatous polyps.

  2006cited by this paper
• Cardiovascular Risk Associated With Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention

  2006cited by this paper
• Lifestyle and medical approaches to cancer prevention.

  2005cited by this paper
• Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States?

  2004cited by this paper
• Polyamines and cancer: old molecules, new understanding

  2004cited by this paper
• Deaths: final data for 2002.

  2004cited by this paper
• A randomized trial of aspirin to prevent colorectal adenomas.

  2003cited by this paper
• Flexible Implementations of Group Sequential Stopping Rules Using Constrained Boundaries

  2003cited by this paper
• A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.

  2003cited by this paper
• Group Sequential Methods with Applications to Clinical Trials

  2001cited by this paper
• Risk of cardiovascular events associated with selective COX-2 inhibitors.

  2001cited by this paper
• Influence of K-ras activation on the survival responses of Caco-2 cells to the chemopreventive agents sulindac and difluoromethylornithine.

  2000cited by this paper
• UC Irvine UC Irvine Previously Published Works Title Development of difluoromethylornithine ( DFMO ) as a chemoprevention agent

  2000cited by this paper
• Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network.

  2000cited by this paper
• Combinatorial chemoprevention of intestinal neoplasia

  2000cited by this paper
• CALCIUM SUPPLEMENTS FOR THE PREVENTION OF COLORECTAL ADENOMAS

  2000cited by this paper
• Comparative toxicity of nonsteroidal anti-inflammatory drugs.

  1999cited by this paper
• Group Sequential Methods with Applications to Clinical Trials

  1999cited by this paper
• A Unifying Family of Group Sequential Test Designs

  1999cited by this paper
• Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group.

  1999cited by this paper
• Effect of a-Difluoromethylornithine on Rectal Mucosal Levels of Polyamines in a Randomized, Double-Blinded Trial for Colon Cancer Prevention

  1998cited by this paper
• Nonsteroidal anti-inflammatory drug-related gastrointestinal toxicity: definitions and epidemiology.

  1998cited by this paper
• Dose de-escalation chemoprevention trial of alpha-difluoromethylornithine in patients with colon polyps.

  1994cited by this paper
• Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.

  1993cited by this paper
• Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.

  1993cited by this paper
• Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.

  1993cited by this paper
• Cancer statistics

  1989cited by this paper
• Inhibition of intestinal carcinogenesis in rats: effect of difluoromethylornithine with piroxicam or fish oil.

  1986cited by this paper
• Combination chemoprevention of cancer

  1980cited by this paper
• A multiple testing procedure for clinical trials.

  1979cited by this paper

• Microbiota-derived metabolites in cancer: Dual roles in pathogenesis and opportunities for therapy

  2026cites this paper
• Polyamine metabolism in cancer: drivers of immune evasion, ferroptosis and therapy resistance

  2025cites this paper
• Innovative horizons: harnessing drug repositioning for targeted therapeutics in colorectal cancer

  2025cites this paper
• Cancer chemoprevention: signaling pathways and strategic approaches

  2025cites this paper
• Emerging Strategies for Drug-Based Cancer Risk Reduction.

  2025cites this paper
• Novel LC-MS/MS assay to quantify D,L-alpha-difluoromethylornithine (DFMO) in mouse plasma.

  2025cites this paper
• AZIN1 level is increased in medulloblastoma and correlates with c-Myc activity and tumor phenotype

  2025cites this paper
• STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma.

  2025cites this paper
• Colorectal cancer chemoprevention: Exploring the path from molecular mechanisms to available drugs.

  2025cites this paper
• Therapeutic Insights into Rubus ulmifolius Schott Leaf Extract: In Vitro Antifungal, Enzyme Inhibition, and Anticancer Activities Integrated with Network Pharmacology and Molecular Docking Analyses of Colorectal and Ovarian Cancer

  2025cites this paper
• Ornithine decarboxylase and its role in cancer.

  2025cites this paper
• Colorectal cancer cell-derived exosomes induce metabolic reprogramming of cancer-associated fibroblasts to promote colorectal cancer growth

  2025cites this paper
• Eflornithine for the Chemoprevention of Luminal Gastrointestinal Neoplasms: A Systematic Review

  2025cites this paper
• High-dose DFMO alters protein translation in neuroblastoma

  2025cites this paper
• Preclinical evaluation of the efficacy of α−Difluoromethylornithine and Sulindac against SARS-CoV-2 infection

  2025cites this paper
• Familial adenomatous polyposis: non-surgical management of large bowel disease: endoscopic and chemoprevention strategies

  2025cites this paper
• Preclinical Evaluation of the Efficacy of α-Difluoromethylornithine and Sulindac Against SARS-CoV-2 Infection

  2025influential citation
• Review of Network Meta-Analyses on the Efficacy of Chemopreventive Agents on Colorectal Adenomas and Cancer

  2025cites this paper
• Monitoring ODC activity and polyamines in Bachmann-Bupp syndrome patient biological samples.

  2025cites this paper
• Identification of biomarkers for the diagnosis in colorectal polyps and metabolic dysfunction-associated steatohepatitis (MASH) by bioinformatics analysis and machine learning

  2024cites this paper
• Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial

  2024cites this paper
• P53-dependent hypusination of eIF5A affects mitochondrial translation and senescence immune surveillance

  2024cites this paper
• Clinical efficacy of metformin in familial adenomatous polyposis and the effect of intestinal flora

  2024cites this paper
• Macrophage Inflammatory Proteins (MIPs) Contribute to Malignant Potential of Colorectal Polyps and Modulate Likelihood of Cancerization Associated with Standard Risk Factors

  2024cites this paper
• Microbiota and detrimental protein derived metabolites in colorectal cancer.

  2024cites this paper
• A Contemporary Review on the Critical Role of Nonsteroidal Anti-inflammatory Agents in Colorectal Cancer Therapy.

  2024cites this paper
• Endoscopic scoring indices for assessing disease severity in familial adenomatous polyposis: Systematic review

  2024cites this paper
• Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats

  2023cites this paper
• Updated Perspectives on the Diagnosis and Management of Familial Adenomatous Polyposis

  2023cites this paper
• Transcriptional Basis of Ca2+ Remodeling Reversal Induced by Polyamine Synthesis Inhibition in Colorectal Cancer Cells

  2023cites this paper
• Modulating the polyamine/hypusine axis controls generation of CD8+ tissue-resident memory T cells

  2023cites this paper
• Chemoprevention of colorectal cancer in general population and high-risk population: a systematic review and network meta-analysis

  2023influential citation
• Chemopreventive strategies for sporadic colorectal cancer: a narrative review

  2023cites this paper
• Mitochondria‐targeted metformin (mitomet) inhibits lung cancer in cellular models and in mice by enhancing the generation of reactive oxygen species

  2023cites this paper
• Hypusination-induced DHPS/eIF5A pathway as a new therapeutic strategy for human diseases: A mechanistic review and structural classification of DHPS inhibitors.

  2023cites this paper
• A View on Drug Development for Cancer Prevention.

  2023cites this paper
• Colorectal Cancer Chemoprevention: A Dream Coming True?

  2023cites this paper
• Reciprocal Regulation of Cancer-Associated Fibroblasts and Tumor Microenvironment in Gastrointestinal Cancer: Implications for Cancer Dormancy

  2023cites this paper
• Combined inhibition of polyamine metabolism and eIF5A hypusination suppresses colorectal cancer growth through a converging effect on MYC translation.

  2023cites this paper
• Phase IIa Clinical Biomarker Trial of Dietary Arginine Restriction and Aspirin in Colorectal Cancer Patients

  2023cites this paper
• Phenolic Phytochemicals for Prevention and Treatment of Colorectal Cancer: A Critical Evaluation of In Vivo Studies

  2023cites this paper
• Major hurdles to the use of tyrosine kinase inhibitors in clinical prevention/interception studies: Do preclinical studies with EGFR inhibitors suggest approaches to overcome some of the limitations

  2023cites this paper
• PRIMARY PREVENTION AND INTERCEPTION STUDIES IN RAS-MUTATED TUMOR MODELS EMPLOYING SMALL MOLECULES OR VACCINES.

  2023cites this paper
• Preventive effects of chemical drugs on recurrence of colorectal adenomas: systematic review and Bayesian network meta-analysis

  2023cites this paper
• Eflornithine for chemoprevention in the high-risk population of colorectal cancer: a systematic review and meta-analysis with trial sequential analysis

  2023cites this paper
• Endoscopic and chemopreventive management of familial adenomatous polyposis syndrome

  2023cites this paper
• Nonsteroidal Anti-inflammatory Drugs for Chemoprevention in Patients With Familial Adenomatous Polyposis: A Systematic Review and Meta-Analysis

  2023cites this paper
• Carrier-Mediated Process of Putrescine Elimination at the Rat Blood–Retinal Barrier

  2023cites this paper
• Bachmann–Bupp syndrome and treatment

  2023cites this paper
• An update on clinical trials for chemoprevention of human skin cancer

  2023cites this paper
• Management of familial adenomatous polyposis and MUTYH-associated polyposis; new insights.

  2022cites this paper
• Drug Repurposing Strategies for Non-Cancer to Cancer Therapeutics.

  2022cites this paper
• Pharmacological targeting of polyamine and hypusine biosynthesis reduces tumour activity of endometrial cancer

  2022cites this paper
• Long-term chemoprevention in patients with adenomatous polyposis coli: an observational study

  2022cites this paper
• Metabolic reprograming of cancer as a therapeutic target.

  2022cites this paper
• Quantitative Metabolomics to Explore the Role of Plasma Polyamines in Colorectal Cancer

  2022cites this paper
• Ornithine Decarboxylase in Gastric Epithelial Cells Promotes the Immunopathogenesis of Helicobacter pylori Infection

  2022cites this paper
• The Association between Spermidine/Spermine N1-Acetyltransferase (SSAT) and Human Malignancies

  2022cites this paper
• 3,3'-Diindolylmethane plus Eflornithine suppress DNA Replication and Cell Cycle in Esophageal Squamous Cell Carcinoma in vivo

  2022cites this paper
• The efficacy of chemopreventive agents on the incidence of colorectal adenomas: A systematic review and network meta-analysis.

  2022cites this paper
• Combination Chemotherapy of Multidrug-resistant Early-stage Colon Cancer: Determining Optimal Dose Schedules by High-performance Computer Simulation

  2022cites this paper
• Hereditary Colorectal Cancer Syndromes: Molecular Genetics and Precision Medicine

  2022cites this paper
• Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma

  2022cites this paper
• Plant Natural Products: Promising Resources for Cancer Chemoprevention

  2021cites this paper
• Management of Familial Adenomatous Polyposis

  2021cites this paper
• Modulating Properties of Piroxicam, Meloxicam and Oxicam Analogues against Macrophage-Associated Chemokines in Colorectal Cancer

  2021cites this paper
• Future incidence and mortality of colorectal carcinoma in the United States: an updated overview of risk factors and preventative measures

  2021cites this paper
• Hearing Status of Children and Adolescents With Familial Adenomatous Polyposis

  2021cites this paper
• Monocyte Chemotactic Proteins (MCP) in Colorectal Adenomas Are Differently Expressed at the Transcriptional and Protein Levels: Implications for Colorectal Cancer Prevention

  2021cites this paper
• Combining repurposed drugs to treat colorectal cancer.

  2021cites this paper
• Repurposing eflornithine to treat a patient with a rare ODC1 gain-of-function variant disease

  2021cites this paper
• Quimioprevenção e câncer no contexto brasileiro: Da higidez ao diagnóstico

  2021cites this paper
• Protective Role of Spermidine in Colitis and Colon Carcinogenesis.

  2021cites this paper
• Combination of Sulindac and Eflornithine Delays the Need for Lower Gastrointestinal Surgery in Patients With Familial Adenomatous Polyposis: Post Hoc Analysis of a Randomized Clinical Trial

  2021cites this paper
• Field carcinogenesis for risk stratification of colorectal cancer.

  2021cites this paper
• Metabolism and function of polyamines in cancer progression.

  2021cites this paper
• The role of polyamines in gastric cancer

  2021cites this paper
• Metformin Inhibits the Urea Cycle and Reduces Putrescine Generation in Colorectal Cancer Cell Lines

  2021cites this paper
• A comprehensive review of herbacetin: From chemistry to pharmacological activities.

  2021cites this paper
• Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment

  2021cites this paper
• Structural basis of binding and inhibition of ornithine decarboxylase by 1-amino-oxy-3-aminopropane.

  2021cites this paper
• Emerging Role of ODC1 in Neurodevelopmental Disorders and Brain Development

  2021cites this paper
• Biphasic Expression of Atypical Chemokine Receptor (ACKR) 2 and ACKR4 in Colorectal Neoplasms in Association with Histopathological Findings

  2020cites this paper
• Lifestyle and Cancer Prevention

  2020cites this paper
• Chemoprevention of Colorectal Cancer.

  2020cites this paper
• Updates in Chemoprevention Research for Hereditary Gastrointestinal and Polyposis Syndromes

  2020cites this paper
• Targeting polyamine as a novel therapy in xenograft models of malignant pleural mesothelioma.

  2020cites this paper
• Stem cell models for genetically predisposed colon cancer.

  2020cites this paper
• L-Arginine/Nitric Oxide Pathway Is Altered in Colorectal Cancer and Can Be Modulated by Novel Derivatives from Oxicam Class of Non-Steroidal Anti-Inflammatory Drugs

  2020cites this paper
• Molecular Targets in Precision Chemoprevention of Colorectal Cancer: An Update from Pre-Clinical to Clinical Trials

  2020cites this paper
• Thymoquinone and Difluoromethylornithine (DFMO) Synergistically Induce Apoptosis of Human Acute T Lymphoblastic Leukemia Jurkat Cells Through the Modulation of Epigenetic Pathways

  2020cites this paper
• Calcium Permeable Channels in Cancer Hallmarks

  2020influential citation
• Distinct Local and Systemic Molecular Signatures in the Esophageal and Gastric Cancers: Possible Therapy Targets and Biomarkers for Gastric Cancer

  2020cites this paper
• Prevention of Colon Cancer Recurrence From Minimal Residual Disease: Computer Optimized Dose Schedules of Intermittent Apoptotic Adjuvant Therapy.

  2020cites this paper
• Anti-GD2 induced allodynia in rats can be reduced by pretreatment with DFMO

  2020cites this paper
• Negative Binomial Regression

  2020cites this paper
• Spermidine as a target for cancer therapy.

  2020cites this paper
• Chemoprevention in familial adenomatous polyposis: past, present and future

  2020cites this paper
• The Role of the Gut Microbiome in Colorectal Cancer Development and Therapy Response

  2020cites this paper
• The efficacy of a leukotriene receptor antagonist in the treatment of human rectal aberrant crypt foci: a nonrandomized, open-label, controlled trial

  2020cites this paper